Insider Lurker Nancy at EyePoint (NASDAQ: EYPT) reports equity grants

Rhea-AI Filing Summary

EyePoint, Inc. director Nancy Lurker reported equity awards and updated share holdings. On January 2, 2026, she was granted a stock option to buy 40,000 shares of common stock at $17.48, exercisable starting January 2, 2027 and expiring January 2, 2036. On January 5, 2026, 12,666 restricted stock units were converted into the same number of common shares at $0.00 per share, leaving her with 219,213 shares of common stock held directly and 12,667 restricted stock units outstanding. Separately, 126,889 shares of common stock are held indirectly through a family trust for her children, with her spouse as trustee, and she disclaims beneficial ownership of those trust-held shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lurker Nancy

(Last) (First) (Middle)

C/O EYEPOINT, INC.

480 PLEASANT STREET, SUITE C400

(Street)

WATERTOWN MA 02472

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EyePoint, Inc. [ EYPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/05/2026		M		12,666	A	$0.00	219,213	D
Common Stock								126,889	I	By Family Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$17.48	01/02/2026		A		40,000		01/02/2027	01/02/2036	Common Stock	40,000	$0.00	40,000	D
Restricted Stock Units	$0.00	01/05/2026		M			12,666	(2)	(2)	Common Stock	12,666	$0.00	12,667	D

Explanation of Responses:

1. These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

2. The restricted stock units vest in three ratable annual installments beginning January 5, 2025.

Remarks:

	/s/ Ron Honig, Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did EyePoint (EYPT) director Nancy Lurker report?

Nancy Lurker reported a grant of a stock option for 40,000 shares at $17.48 on January 2, 2026, and the conversion of 12,666 restricted stock units into common stock on January 5, 2026.

How many EyePoint (EYPT) shares does Nancy Lurker hold directly after these transactions?

After the reported transactions, Nancy Lurker directly holds 219,213 shares of EyePoint common stock and 12,667 restricted stock units.

What are the terms of Nancy Lurker’s EyePoint (EYPT) stock option grant?

The filing shows a stock option (right to buy) for 40,000 shares of EyePoint common stock with an exercise price of $17.48, exercisable starting January 2, 2027 and expiring January 2, 2036.

How do the restricted stock units (RSUs) for EyePoint (EYPT) director Nancy Lurker vest?

According to the footnote, Nancy Lurker’s restricted stock units vest in three ratable annual installments beginning January 5, 2025. The January 5, 2026 transaction reflects part of this vesting schedule.

What EyePoint (EYPT) shares are held through the family trust related to Nancy Lurker?

The Form 4 states that 126,889 shares of EyePoint common stock are held indirectly by a family trust for the benefit of her children, with her spouse as trustee, and that she disclaims beneficial ownership of those securities.

Is Nancy Lurker considered a 10% owner of EyePoint (EYPT) in this filing?

No. The Form 4 identifies Nancy Lurker as a director of EyePoint, Inc. and does not mark her as a 10% owner.